Table 1.

Demographics

Stratum	1		2
Dose:	Dose Level 1 8 Gy x 2 (n = 6)	Dose Level 2 8 Gy x 3 (n = 4)	Dose Level 1 6 Gy x 2 (n = 6)	Dose Level 2 6 Gy x 3 (n = 6)
Site of index (irradiated) lesion	Lung	lung	liver/ subcutaneous	liver/ subcutaneous
Prior Therapy*
Treatment-naïve	2 (33%)	3 (75%)	3 (50%)	3 (50%)
Treatment-refractory	4 (67%)	1 (25%)	3 (50%)	3 (50%)
Stage
M1a	0	0	0	2 (33%)
M1b	2 (33%)	2 (50%)	0	2 (33%)
M1c	4 (67%)	2 (50%)	6 (100%)	2 (33%)
LDH
Elevated	4 (67%)	1 (25%)	3 (50%)	2 (50%)
Not elevated	2 (33%)	3 (75%)	3 (50%)	2 (50%)
Gender
Male	5 (83%)	2 (50)	5 (83)	5 (83)
Female	1 (17%)	2 (50)	1 (17%)	1 (17%)
Patient age in years, n (%)
18–44	0	0	0	0
45–64	3 (50)	3 (75)	2 (33)	0
≥65	3 (50)	1 (25%)	4 (67)	6 (100)
Patients with ECOG PS, n (%)
0	4 (67)	3 (75)	3 (50)	2 (33)
1	2 (33)	1 (25%)	3 (50)	4 (67)

*Prior Therapies Detailed in Supplemental Table 1.